Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mehdi Asadi

Showing results (41-50 of 69) with videos related to

Pageof 7
Sort By:
Chemistry & Biodiversity|June 4, 2019
Design, Synthesis, and Cholinesterase Inhibition Assay of Coumarin-3-carboxamide-N-morpholine Hybrids as New Anti-Alzheimer AgentsMaliheh Barazandeh Tehrani, Zahra Rezaei, Mehdi Asadi, et al.
ACS Omega|June 20, 2022
Isoindolin-1-ones Fused to Barbiturates: From Design and Molecular Docking to Synthesis and Urease Inhibitory EvaluationHouman Kazemzadeh, Elham Hamidian, Faezeh Sadat Hosseini, et al.
Bioorganic & Medicinal Chemistry|September 8, 2018
Design, synthesis, and biological evaluation of selective and potent Carbazole-based butyrylcholinesterase inhibitorsRoshanak Ghobadian, Hamid Nadri, Alireza Moradi, et al.
Molecular Diversity|March 22, 2019
Novel fused 1,2,3-triazolo-benzodiazepine derivatives as potent anticonvulsant agents: design, synthesis, in vivo, and in silico evaluationsArefeh Shafie, Maryam Mohammadi-Khanaposhtani, Mehdi Asadi, et al.
Bioorganic Chemistry|December 16, 2019
Synthesis and biological evaluation of new benzimidazole-1,2,3-triazole hybrids as potential α-glucosidase inhibitorsNafise Asemanipoor, Maryam Mohammadi-Khanaposhtani, Shahram Moradi, et al.
Chemistry & Biodiversity|September 17, 2019
Design, Synthesis, Molecular Docking, and Cholinesterase Inhibitory Potential of Phthalimide-Dithiocarbamate Hybrids as New Agents for Treatment of Alzheimer's DiseaseMehdi Asadi, Mostafa Ebrahimi, Maryam Mohammadi-Khanaposhtani, et al.
Scientific Reports|May 20, 2021
Arylmethylene hydrazine derivatives containing 1,3-dimethylbarbituric moiety as novel urease inhibitorsKeyvan Pedrood, Homa Azizian, Mohammad Nazari Montazer, et al.
Archiv Der Pharmazie|March 20, 2015
N-(2-(Piperazin-1-yl)phenyl)arylamide Derivatives as β-Secretase (BACE1) Inhibitors: Simple Synthesis by Ugi Four-Component Reaction and Biological EvaluationNajmeh Edraki, Omidreza Firuzi, Yousef Fatahi, et al.
Scientific Reports|July 28, 2024
Synthesis, α-glucosidase inhibitory activity, and molecular dynamic simulation of 6-chloro-2-methoxyacridine linked to triazole derivativesMehdi Asadi, Mohammad Mehdi Ahangari, Aida Iraji, et al.
Archiv Der Pharmazie|April 9, 2024
New phenylthiosemicarbazide-phenoxy-1,2,3-triazole-N-phenylacetamides as dual inhibitors against α-glucosidase and PTP-1B for the treatment of type 2 diabetesShirin Ansariashlaghi, Azadeh Fakhrioliaei, Maryam Mohammadi-Khanaposhtani, et al.
Pageof 7

Showing results (41-50 of 69) with videos related to

Sort By:
Pageof 7
Chemistry & Biodiversity|June 4, 2019
Design, Synthesis, and Cholinesterase Inhibition Assay of Coumarin-3-carboxamide-N-morpholine Hybrids as New Anti-Alzheimer AgentsMaliheh Barazandeh Tehrani, Zahra Rezaei, Mehdi Asadi, et al.
ACS Omega|June 20, 2022
Isoindolin-1-ones Fused to Barbiturates: From Design and Molecular Docking to Synthesis and Urease Inhibitory EvaluationHouman Kazemzadeh, Elham Hamidian, Faezeh Sadat Hosseini, et al.
Bioorganic & Medicinal Chemistry|September 8, 2018
Design, synthesis, and biological evaluation of selective and potent Carbazole-based butyrylcholinesterase inhibitorsRoshanak Ghobadian, Hamid Nadri, Alireza Moradi, et al.
Molecular Diversity|March 22, 2019
Novel fused 1,2,3-triazolo-benzodiazepine derivatives as potent anticonvulsant agents: design, synthesis, in vivo, and in silico evaluationsArefeh Shafie, Maryam Mohammadi-Khanaposhtani, Mehdi Asadi, et al.
Bioorganic Chemistry|December 16, 2019
Synthesis and biological evaluation of new benzimidazole-1,2,3-triazole hybrids as potential α-glucosidase inhibitorsNafise Asemanipoor, Maryam Mohammadi-Khanaposhtani, Shahram Moradi, et al.
Chemistry & Biodiversity|September 17, 2019
Design, Synthesis, Molecular Docking, and Cholinesterase Inhibitory Potential of Phthalimide-Dithiocarbamate Hybrids as New Agents for Treatment of Alzheimer's DiseaseMehdi Asadi, Mostafa Ebrahimi, Maryam Mohammadi-Khanaposhtani, et al.
Scientific Reports|May 20, 2021
Arylmethylene hydrazine derivatives containing 1,3-dimethylbarbituric moiety as novel urease inhibitorsKeyvan Pedrood, Homa Azizian, Mohammad Nazari Montazer, et al.
Archiv Der Pharmazie|March 20, 2015
N-(2-(Piperazin-1-yl)phenyl)arylamide Derivatives as β-Secretase (BACE1) Inhibitors: Simple Synthesis by Ugi Four-Component Reaction and Biological EvaluationNajmeh Edraki, Omidreza Firuzi, Yousef Fatahi, et al.
Scientific Reports|July 28, 2024
Synthesis, α-glucosidase inhibitory activity, and molecular dynamic simulation of 6-chloro-2-methoxyacridine linked to triazole derivativesMehdi Asadi, Mohammad Mehdi Ahangari, Aida Iraji, et al.
Archiv Der Pharmazie|April 9, 2024
New phenylthiosemicarbazide-phenoxy-1,2,3-triazole-N-phenylacetamides as dual inhibitors against α-glucosidase and PTP-1B for the treatment of type 2 diabetesShirin Ansariashlaghi, Azadeh Fakhrioliaei, Maryam Mohammadi-Khanaposhtani, et al.
Pageof 7